Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2026-09-17 16:05:30 ET · period of report 2026-09-15 · accession 0001193125-26-394323 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:05 | 2026-09-15 | IRWD | DENNER ALEXANDER J | Dir | A - Grant | $0.00 | +3,694 | 327.5K | +1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-09-15 | A | A | 3,694 | $0.00 | 327,549 | D | — | — | (F1) Issued pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024. |